{"id":2696,"date":"2019-10-07T16:08:26","date_gmt":"2019-10-07T14:08:26","guid":{"rendered":"https:\/\/idibell.cat\/?page_id=2696"},"modified":"2024-06-20T13:00:27","modified_gmt":"2024-06-20T11:00:27","slug":"immune-inflammatory-processes-and-gene-therapeutics","status":"publish","type":"page","link":"https:\/\/idibell.cat\/en\/research\/translational-medicine-area\/genes-disease-and-therapy-program\/immune-inflammatory-processes-and-gene-therapeutics\/","title":{"rendered":"Immune-inflammatory Processes and Gene Therapeutics"},"content":{"rendered":"\n<h1>\n\t\tImmune-inflammatory processes and gene therapeutics\n\t<\/h1>\n<h3>\n\t\tSummary\n\t<\/h3>\n\t<p>The Immune-inflammatory Processes and Gene Therapy research group carries out translational research with a primary focus on the molecular basis of immune-inflammatory processes. Its aim is to promote relevant, high-quality research into inflammation and to provide an optimal environment for training young researchers.<\/p>\n<p>&nbsp;<\/p>\n<h2>88<\/h2>\n<h2>Publications<\/h2>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/idibell.cat\/en\/wp-content\/uploads\/sites\/2\/2020\/04\/902_aran.png\" alt=\"902_aran\" itemprop=\"image\" height=\"300\" width=\"600\" title=\"902_aran\" onerror=\"this.style.display='none'\"  \/>\n\t\t\t\t\t<a href=\"#\" id=\"fl-accordion--label-0\" tabindex=\"0\" aria-controls=\"fl-accordion--panel-0\">Strategic lines<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"#\" id=\"fl-accordion--icon-0\" tabindex=\"0\" aria-controls=\"fl-accordion--panel-0\"><i>Expand<\/i><\/a>\n\t\t\t\t\tIdentification and characterisation of new immunomodulatory proteins and evaluation of their relevance and therapeutic potential in immune-mediated inflammatory diseases.<br \/>\nAnalysis of new diagnostic\/prognostic biomarkers in acute and chronic inflammatory pathologies.<br \/>\nOxidative stress in epithelial cells of the respiratory pathways. Inflammatory molecular mechanisms.\n\t\t\t\t\t<a href=\"#\" id=\"fl-accordion--label-1\" tabindex=\"0\" aria-controls=\"fl-accordion--panel-1\">Selected Publications<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"#\" id=\"fl-accordion--icon-1\" tabindex=\"0\" aria-controls=\"fl-accordion--panel-1\"><i>Expand<\/i><\/a>\n\t\t\t\t\t<ul>\n<li>Serrano,I;Luque,A;Ruiz Cerulla,A;Navas,S;Blom,AM;de C\u00f3rdoba,SR;Fern\u00e1ndez,FJ et al, <strong>C4BP(\u00df-)-mediated immunomodulation attenuates inflammation in DSS-induced murine colitis and in myeloid cells from IBD patients<\/strong>, Pharmacol. Res., 2023;197106948-106948, doi:10.1016\/j.phrs.2023.106948,<\/li>\n<li>Serrano I, Luque A, Mitjavila F, Blom AM, Rodr\u00edguez de C\u00f3rdoba S, Vega MC, Torras J, Aran JM. <strong>The Hidden Side of Complement Regulator C4BP: Dissection and Evaluation of Its Immunomodulatory Activity<\/strong>. Front. Immunol. 2022;13883743-883743. doi:10.3389\/fimmu.2022.883743.<\/li>\n<li>Checa J, Martinez Gonzalez I, Maqueda M, Mosquera JL, Aran JM.<strong> Genome-Wide RNAi Screening Identifies Novel Pathways\/Genes Involved in Oxidative Stress and Repurposable Drugs to Preserve Cystic Fibrosis Airway Epithelial Cell Integrity<\/strong>. Antioxidants. 2021;10(12):doi:10.3390\/antiox10121936.<\/li>\n<li>Hueso M, Mall\u00e9n A, Su\u00f1\u00e9 Pou M, Aran JM, Su\u00f1\u00e9 Negre JM, Navarro E. <strong>ncRNAs in Therapeutics: Challenges and Limitations in Nucleic Acid-Based Drug Delivery.<\/strong> Int J Mol Sci. 2021;22(21):doi:10.3390\/ijms222111596.<\/li>\n<li>Guiteras J, Ripoll E, Bolanos N, de Ramon L, Fontova P, Lloberas N, Cruzado JM, Aran JM, Avino A, Eritja R, Goma M, Taco R, Grinyo JM, Torras J. <strong>The gene silencing of IRF5 and BLYSS effectively modulates the outcome of experimental lupus nephritis<\/strong>. Mol. Ther. Nucl. Acids. 2021;24807-821. doi:10.1016\/j.omtn.2021.03.019.<\/li>\n<\/ul>\n\t\t\t\t\t<a href=\"#\" id=\"fl-accordion--label-2\" tabindex=\"0\" aria-controls=\"fl-accordion--panel-2\">Selected Projects<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"#\" id=\"fl-accordion--icon-2\" tabindex=\"0\" aria-controls=\"fl-accordion--panel-2\"><i>Expand<\/i><\/a>\n\t\t\t\t\t<ul>\n<li>FIS23037. <strong>Caracterizaci\u00f3n de Heptammune, un nuevo inmunomodulador biol\u00f3gico para controlar la hiperinflamaci\u00f3n y la inmunidad entrenada desadaptada en enfermedades autoinmunes<\/strong>. Instituto de Salud Carlos III (ISCIII). Budget: 252.500\u20ac. 2024-2026. PI: ARAN PERRAMON, JOSEP M\u00aa.<\/li>\n<li>21FIS019. <strong>Caracterizaci\u00f3n, potencial diagn\u00f3stico y terape\u00fatico de un nuevo inmunomodulador biol\u00f3gico para el tratamiento de enfermedades autoinmunes<\/strong>. Instituto de Salud Carlos III (ISCIII). Budget: 171.820\u20ac. 2021-2025. PI: ARAN PERRAMON, JOSEP M\u00aa.<\/li>\n<li>21FIS011. <strong>Desarrollo de un nuevo biol\u00f3gico restaurador de la tolerancia inmunitaria. Aplicaci\u00f3n al tratamiento de la enfermedad inflamatoria intestinal<\/strong>. Instituto de Salud Carlos III (ISCIII). Budget: 115.500\u20ac. 2021-2023. PI: ARAN PERRAMON, JOSEP M\u00aa.<\/li>\n<li>AGA22021. <strong>PurPose Biotherapeutics: first-in-class metabolic modulators against autoimmune diseases<\/strong>. AGENCIA GESTIO D&#8217;AJUTS UNIV. I RECERCA. Budget: 84.000,06\u20ac. 2022-2024. PI: ARAN PERRAMON, JOSEP M\u00aa.<\/li>\n<li>LCX22001. <strong>PRP6-HO7: a first-in-class biologic immunomodulator against autoimmune diseases<\/strong>. FUNDACI\u00d3 &#8220;LA CAIXA&#8221;. Budget: 70.000\u20ac. 2022-2024. PI: ARAN PERRAMON, JOSEP M\u00aa.<\/li>\n<\/ul>\n\t\t\t\t\t<a href=\"#\" id=\"fl-accordion--label-3\" tabindex=\"0\" aria-controls=\"fl-accordion--panel-3\">Technology transfer<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"#\" id=\"fl-accordion--icon-3\" tabindex=\"0\" aria-controls=\"fl-accordion--panel-3\"><i>Expand<\/i><\/a>\n\t\t\t\t\tPAT10- &#8220;Compositions and methods for immunomodulation&#8221;<br \/>\nIP: Josep Maria Aran<br \/>\nOWNERSHIP:100% IDIBELL<br \/>\nREQUEST No.: EP11382240<br \/>\nPRIORITY COUNTRY: European Union<br \/>\nPRIORITY DATE: 15\/07\/11<br \/>\nPCT APPLICATION: PCT\/EP2012\/063932 (16\/07\/12)\nPAT057-Predictive methods of atherosclerosis and stenosis<br \/>\nEP16382025<br \/>\nIP: Josep Maria Aran, Ana Luque\nPAT62- &#8220;C4BP-based compounds for treating immunological diseases&#8221;<br \/>\nOWNERSHIP:100% IDIBELL<br \/>\nREQUEST No.: EP17382187<br \/>\nPRIORITY COUNTRY: European Union<br \/>\nPRIORITY DATE: 06\/04\/17<br \/>\nPCT APPLICATION: PCT\/EP2018\/058773 (06\/07\/18)\nPAT76- &#8220;Compounds for immunomodulation&#8221;<br \/>\nINVENTORS: Aran, J.M., Luque, A., Serrano, I.<br \/>\nOWNERSHIP:100% IDIBELL<br \/>\nREQUEST No.: EP19382910<br \/>\nPRIORITY COUNTRY: European Union<br \/>\nPRIORITY DATE: 17\/10\/19\nLicense: ISR-TEST: Test r\u00e0pid pel diagn\u00f2stic del risc d&#8217;ICTUS<br \/>\nPI: Dr. Josep Maria Aran\n\t\t\t\t<img decoding=\"async\" src=\"https:\/\/idibell.cat\/wp-content\/uploads\/2019\/10\/aran-perramon-jose-maria-150x150.jpg\" alt=\"Aran Perramon, Jose Maria\" itemprop=\"image\" title=\"aran-perramon-jose-maria\" onerror=\"this.style.display='none'\"  \/>\n<h4>\n\t\tAran Perramon, Jose Maria\n\t<\/h4>\n<h4>\n\t\t<a href=\"mailto:vmoreno@idibell.cat\" title=\"jaran@idibell.cat\" target=\"_blank\" rel=\"noopener\">\n\t\tjaran@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n<h2>\n\t\tPrincipal investigators\n\t<\/h2>\n\t\t\t\t<img decoding=\"async\" src=\"https:\/\/idibell.cat\/wp-content\/uploads\/2019\/10\/aran-perramon-jose-maria-150x150.jpg\" alt=\"Aran Perramon, Jose Maria\" itemprop=\"image\" title=\"aran-perramon-jose-maria\" onerror=\"this.style.display='none'\"  \/>\n<h4>\n\t\tAran Perramon, Jose Maria\n\t<\/h4>\n<h4>\n\t\t<a href=\"mailto:vmoreno@idibell.cat\" title=\"jaran@idibell.cat\" target=\"_blank\" rel=\"noopener\">\n\t\tjaran@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n<h2>\n\t\tTeam\n\t<\/h2>\n\t\t\t\t\t\t\t\t<a href=\"#\" id=\"fl-tabs--label-0\" data-index=\"0\" aria-selected=\"true\" aria-controls=\"fl-tabs--panel-0\" aria-expanded=\"true\" role=\"tab\" tabindex=\"0\">\t\t\t\tGroup leaders\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<a href=\"#\" id=\"fl-tabs--label-1\" data-index=\"1\" aria-selected=\"false\" aria-controls=\"fl-tabs--panel-1\" aria-expanded=\"false\" role=\"tab\" tabindex=\"0\">\t\t\t\tPostdoctoral researchers\t\t\t\t<\/a>\n\t\t\t\t\t\tGroup leaders\n\t\t\t\t\t\t\t\t\t\t\t<ul>\n<li>Aran Perramon, Jose Maria<\/li>\n<\/ul>\n\t\t\t\t\t\tPostdoctoral researchers\n\t\t\t\t\t\t\t\t\t\t\t<ul>\n<li>Luque Gomez, Ana<\/li>\n<li>Serrano Santacruz, Inmaculada<\/li>\n<\/ul>\n<h2>\n\t\tRelated news\n\t<\/h2>\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/WebPage\" itemid=\"http:\/\/23144\" content=\"Scientists describe a new biological drug capable of restoring the immune system homeostasis\" \/><meta itemprop=\"datePublished\" content=\"2023-10-31\" \/><meta itemprop=\"dateModified\" content=\"2023-10-31\" \/><meta itemprop=\"name\" content=\"IDIBELL\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/en\/wp-content\/uploads\/sites\/2\/2022\/05\/Marca-B-e1651478109730.png\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/en\/author\/comunicacio\/\" \/><meta itemprop=\"name\" content=\"comunicacio\" \/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/en\/wp-content\/uploads\/sites\/2\/2023\/10\/thumbnail_IMG_4570.jpg\" \/><meta itemprop=\"width\" content=\"1366\" \/><meta itemprop=\"height\" content=\"768\" \/><meta itemprop=\"interactionType\" content=\"https:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/>\t\n\t\t\t\t<a href=\"https:\/\/idibell.cat\/en\/2023\/10\/describe-a-new-biological-drug-capable-of-restoring-the-immune-system-homeostasis\/\" title=\"Scientists describe a new biological drug capable of restoring the immune system homeostasis\"><\/a>\n\t\t\t<a href=\"https:\/\/idibell.cat\/en\/2023\/10\/describe-a-new-biological-drug-capable-of-restoring-the-immune-system-homeostasis\/\" title=\"Scientists describe a new biological drug capable of restoring the immune system homeostasis\">Scientists describe a new biological drug capable of restoring the immune system homeostasis<\/a>\n\t\t\tBy <a href=\"https:\/\/idibell.cat\/en\/author\/comunicacio\/\">comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t  |  \n\t\t\t\t\t\t\t\t\t31\/10\/2023\t\t\t\t\t\t\t\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/WebPage\" itemid=\"http:\/\/21681\" content=\"hna Foundation collaborates in the development of a new drug against inflammatory bowel diseases\" \/><meta itemprop=\"datePublished\" content=\"2022-12-19\" \/><meta itemprop=\"dateModified\" content=\"2022-12-16\" \/><meta itemprop=\"name\" content=\"IDIBELL\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/en\/wp-content\/uploads\/sites\/2\/2022\/05\/Marca-B-e1651478109730.png\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/en\/author\/comunicacio\/\" \/><meta itemprop=\"name\" content=\"comunicacio\" \/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/en\/wp-content\/uploads\/sites\/2\/2022\/12\/NP30-JM-Aran_Proj-HNA-Imatge-noti.jpg\" \/><meta itemprop=\"width\" content=\"1366\" \/><meta itemprop=\"height\" content=\"768\" \/><meta itemprop=\"interactionType\" content=\"https:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/>\t\n\t\t\t\t<a href=\"https:\/\/idibell.cat\/en\/2022\/12\/hna-foundation-collaborates-in-the-development-of-a-new-drug-against-inflammatory-bowel-diseases\/\" title=\"hna Foundation collaborates in the development of a new drug against inflammatory bowel diseases\"><\/a>\n\t\t\t<a href=\"https:\/\/idibell.cat\/en\/2022\/12\/hna-foundation-collaborates-in-the-development-of-a-new-drug-against-inflammatory-bowel-diseases\/\" title=\"hna Foundation collaborates in the development of a new drug against inflammatory bowel diseases\">hna Foundation collaborates in the development of a new drug against inflammatory bowel diseases<\/a>\n\t\t\tBy <a href=\"https:\/\/idibell.cat\/en\/author\/comunicacio\/\">comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t  |  \n\t\t\t\t\t\t\t\t\t19\/12\/2022\t\t\t\t\t\t\t\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/WebPage\" itemid=\"http:\/\/20536\" content=\"IDIBELL researchers present a new recombinant protein that reverses the proinflammatory state of cells in patients with lupus\" \/><meta itemprop=\"datePublished\" content=\"2022-05-10\" \/><meta itemprop=\"dateModified\" content=\"2022-05-10\" \/><meta itemprop=\"name\" content=\"IDIBELL\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/en\/wp-content\/uploads\/sites\/2\/2022\/05\/Marca-B-e1651478109730.png\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/en\/author\/comunicacio\/\" \/><meta itemprop=\"name\" content=\"comunicacio\" \/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/en\/wp-content\/uploads\/sites\/2\/2022\/05\/NO47-JM-Aran_Frontiers-Immunol-Imatge.jpg\" \/><meta itemprop=\"width\" content=\"1366\" \/><meta itemprop=\"height\" content=\"768\" \/><meta itemprop=\"interactionType\" content=\"https:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/>\t\n\t\t\t\t<a href=\"https:\/\/idibell.cat\/en\/2022\/05\/idibell-researchers-present-a-new-recombinant-protein-that-reverses-the-proinflammatory-state-of-cells-in-patients-with-lupus\/\" title=\"IDIBELL researchers present a new recombinant protein that reverses the proinflammatory state of cells in patients with lupus\"><\/a>\n\t\t\t<a href=\"https:\/\/idibell.cat\/en\/2022\/05\/idibell-researchers-present-a-new-recombinant-protein-that-reverses-the-proinflammatory-state-of-cells-in-patients-with-lupus\/\" title=\"IDIBELL researchers present a new recombinant protein that reverses the proinflammatory state of cells in patients with lupus\">IDIBELL researchers present a new recombinant protein that reverses the proinflammatory state of cells in patients with lupus<\/a>\n\t\t\tBy <a href=\"https:\/\/idibell.cat\/en\/author\/comunicacio\/\">comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t  |  \n\t\t\t\t\t\t\t\t\t10\/05\/2022\t\t\t\t\t\t\t\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/WebPage\" itemid=\"http:\/\/19316\" content=\"Finding new paths in the treatment of cystic fibrosis\" \/><meta itemprop=\"datePublished\" content=\"2021-12-29\" \/><meta itemprop=\"dateModified\" content=\"2021-12-23\" \/><meta itemprop=\"name\" content=\"IDIBELL\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/en\/wp-content\/uploads\/sites\/2\/2022\/05\/Marca-B-e1651478109730.png\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/en\/author\/comunicacio\/\" \/><meta itemprop=\"name\" content=\"comunicacio\" \/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/en\/wp-content\/uploads\/sites\/2\/2021\/12\/NO119-JM-Aran_Antioxidants-Imatge.jpg\" \/><meta itemprop=\"width\" content=\"1366\" \/><meta itemprop=\"height\" content=\"768\" \/><meta itemprop=\"interactionType\" content=\"https:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/>\t\n\t\t\t\t<a href=\"https:\/\/idibell.cat\/en\/2021\/12\/finding-new-paths-in-the-treatment-of-cystic-fibrosis\/\" title=\"Finding new paths in the treatment of cystic fibrosis\"><\/a>\n\t\t\t<a href=\"https:\/\/idibell.cat\/en\/2021\/12\/finding-new-paths-in-the-treatment-of-cystic-fibrosis\/\" title=\"Finding new paths in the treatment of cystic fibrosis\">Finding new paths in the treatment of cystic fibrosis<\/a>\n\t\t\tBy <a href=\"https:\/\/idibell.cat\/en\/author\/comunicacio\/\">comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t  |  \n\t\t\t\t\t\t\t\t\t29\/12\/2021\t\t\t\t\t\t\t\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/WebPage\" itemid=\"http:\/\/19188\" content=\"IDIBELL offers 10 projects for incoming INPhINIT fellowships\" \/><meta itemprop=\"datePublished\" content=\"2021-11-18\" \/><meta itemprop=\"dateModified\" content=\"2021-11-25\" \/><meta itemprop=\"name\" content=\"IDIBELL\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/en\/wp-content\/uploads\/sites\/2\/2022\/05\/Marca-B-e1651478109730.png\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/en\/author\/comunicacio\/\" \/><meta itemprop=\"name\" content=\"comunicacio\" \/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/en\/wp-content\/uploads\/sites\/2\/2021\/11\/FFBWFunXoAQfIw4-1.jpg\" \/><meta itemprop=\"width\" content=\"1366\" \/><meta itemprop=\"height\" content=\"768\" \/><meta itemprop=\"interactionType\" content=\"https:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/>\t\n\t\t\t\t<a href=\"https:\/\/idibell.cat\/en\/2021\/11\/idibell-offers-10-projects-for-incoming-inphinit-fellowships\/\" title=\"IDIBELL offers 10 projects for incoming INPhINIT fellowships\"><\/a>\n\t\t\t<a href=\"https:\/\/idibell.cat\/en\/2021\/11\/idibell-offers-10-projects-for-incoming-inphinit-fellowships\/\" title=\"IDIBELL offers 10 projects for incoming INPhINIT fellowships\">IDIBELL offers 10 projects for incoming INPhINIT fellowships<\/a>\n\t\t\tBy <a href=\"https:\/\/idibell.cat\/en\/author\/comunicacio\/\">comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t  |  \n\t\t\t\t\t\t\t\t\t18\/11\/2021\t\t\t\t\t\t\t\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/WebPage\" itemid=\"http:\/\/14971\" content=\"Funding to study new drugs against autoimmune diseases\" \/><meta itemprop=\"datePublished\" content=\"2020-10-29\" \/><meta itemprop=\"dateModified\" content=\"2020-10-29\" \/><meta itemprop=\"name\" content=\"IDIBELL\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/en\/wp-content\/uploads\/sites\/2\/2022\/05\/Marca-B-e1651478109730.png\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/en\/author\/comunicacio\/\" \/><meta itemprop=\"name\" content=\"comunicacio\" \/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/en\/wp-content\/uploads\/sites\/2\/2020\/10\/Imatge-1.jpg\" \/><meta itemprop=\"width\" content=\"1366\" \/><meta itemprop=\"height\" content=\"768\" \/><meta itemprop=\"interactionType\" content=\"https:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/>\t\n\t\t\t\t<a href=\"https:\/\/idibell.cat\/en\/2020\/10\/funding-to-study-new-drugs-against-autoimmune-diseases\/\" title=\"Funding to study new drugs against autoimmune diseases\"><\/a>\n\t\t\t<a href=\"https:\/\/idibell.cat\/en\/2020\/10\/funding-to-study-new-drugs-against-autoimmune-diseases\/\" title=\"Funding to study new drugs against autoimmune diseases\">Funding to study new drugs against autoimmune diseases<\/a>\n\t\t\tBy <a href=\"https:\/\/idibell.cat\/en\/author\/comunicacio\/\">comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t  |  \n\t\t\t\t\t\t\t\t\t29\/10\/2020\t\t\t\t\t\t\t\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/WebPage\" itemid=\"http:\/\/4930\" content=\"IDIBELL researchers discover that a molecule of blood is effective against autoimmune kidney disease\" \/><meta itemprop=\"datePublished\" content=\"2020-02-03\" \/><meta itemprop=\"dateModified\" content=\"2020-05-05\" \/><meta itemprop=\"name\" content=\"IDIBELL\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/en\/wp-content\/uploads\/sites\/2\/2022\/05\/Marca-B-e1651478109730.png\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/en\/author\/erigin\/\" \/><meta itemprop=\"name\" content=\"Idibell\" \/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/en\/wp-content\/uploads\/sites\/2\/2020\/05\/np48_-_jm_aran_nefritis_lupica_-_image_team_1-1.jpg\" \/><meta itemprop=\"width\" content=\"1280\" \/><meta itemprop=\"height\" content=\"960\" \/><meta itemprop=\"interactionType\" content=\"https:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/>\t\n\t\t\t\t<a href=\"https:\/\/idibell.cat\/en\/2020\/02\/idibell-researchers-discover-that-a-molecule-of-blood-is-effective-against-autoimmune-kidney-disease\/\" title=\"IDIBELL researchers discover that a molecule of blood is effective against autoimmune kidney disease\"><\/a>\n\t\t\t<a href=\"https:\/\/idibell.cat\/en\/2020\/02\/idibell-researchers-discover-that-a-molecule-of-blood-is-effective-against-autoimmune-kidney-disease\/\" title=\"IDIBELL researchers discover that a molecule of blood is effective against autoimmune kidney disease\">IDIBELL researchers discover that a molecule of blood is effective against autoimmune kidney disease<\/a>\n\t\t\tBy <a href=\"https:\/\/idibell.cat\/en\/author\/erigin\/\">Idibell<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t  |  \n\t\t\t\t\t\t\t\t\t03\/02\/2020\t\t\t\t\t\t\t\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/WebPage\" itemid=\"http:\/\/5142\" content=\"Paperdrop Diagnostics, IDIBELL and M\u00fatuaTerrassa collaborate in the design of the first quick test to predict ischemic stroke\" \/><meta itemprop=\"datePublished\" content=\"2019-02-22\" \/><meta itemprop=\"dateModified\" content=\"2020-05-15\" \/><meta itemprop=\"name\" content=\"IDIBELL\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/en\/wp-content\/uploads\/sites\/2\/2022\/05\/Marca-B-e1651478109730.png\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/en\/author\/erigin\/\" \/><meta itemprop=\"name\" content=\"Idibell\" \/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/en\/wp-content\/uploads\/sites\/2\/2020\/05\/img_grup_paperdrop-1-scaled.jpg\" \/><meta itemprop=\"width\" content=\"2560\" \/><meta itemprop=\"height\" content=\"1920\" \/><meta itemprop=\"interactionType\" content=\"https:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/>\t\n\t\t\t\t<a href=\"https:\/\/idibell.cat\/en\/2019\/02\/paperdrop-diagnostics-idibell-and-mutuaterrassa-collaborate-in-the-design-of-the-first-quick-test-to-predict-ischemic-stroke\/\" title=\"Paperdrop Diagnostics, IDIBELL and M\u00fatuaTerrassa collaborate in the design of the first quick test to predict ischemic stroke\"><\/a>\n\t\t\t<a href=\"https:\/\/idibell.cat\/en\/2019\/02\/paperdrop-diagnostics-idibell-and-mutuaterrassa-collaborate-in-the-design-of-the-first-quick-test-to-predict-ischemic-stroke\/\" title=\"Paperdrop Diagnostics, IDIBELL and M\u00fatuaTerrassa collaborate in the design of the first quick test to predict ischemic stroke\">Paperdrop Diagnostics, IDIBELL and M\u00fatuaTerrassa collaborate in the design of the first quick test to predict ischemic stroke<\/a>\n\t\t\tBy <a href=\"https:\/\/idibell.cat\/en\/author\/erigin\/\">Idibell<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t  |  \n\t\t\t\t\t\t\t\t\t22\/02\/2019\t\t\t\t\t\t\t\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/WebPage\" itemid=\"http:\/\/5513\" content=\"IDIBELL and the Llobregat Business Forum, together in the 1st Research charity night\" \/><meta itemprop=\"datePublished\" content=\"2016-11-03\" \/><meta itemprop=\"dateModified\" content=\"2020-05-18\" \/><meta itemprop=\"name\" content=\"IDIBELL\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/en\/wp-content\/uploads\/sites\/2\/2022\/05\/Marca-B-e1651478109730.png\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/en\/author\/erigin\/\" \/><meta itemprop=\"name\" content=\"Idibell\" \/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/en\/wp-content\/uploads\/sites\/2\/2020\/05\/20161115_Nit-solidaria-AEBALL-3-3-scaled.jpg\" \/><meta itemprop=\"width\" content=\"2560\" \/><meta itemprop=\"height\" content=\"1877\" \/><meta itemprop=\"interactionType\" content=\"https:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/>\t\n\t\t\t\t<a href=\"https:\/\/idibell.cat\/en\/2016\/11\/idibell-and-the-llobregat-business-forum-together-in-the-1st-research-charity-night\/\" title=\"IDIBELL and the Llobregat Business Forum, together in the 1st Research charity night\"><\/a>\n\t\t\t<a href=\"https:\/\/idibell.cat\/en\/2016\/11\/idibell-and-the-llobregat-business-forum-together-in-the-1st-research-charity-night\/\" title=\"IDIBELL and the Llobregat Business Forum, together in the 1st Research charity night\">IDIBELL and the Llobregat Business Forum, together in the 1st Research charity night<\/a>\n\t\t\tBy <a href=\"https:\/\/idibell.cat\/en\/author\/erigin\/\">Idibell<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t  |  \n\t\t\t\t\t\t\t\t\t03\/11\/2016\t\t\t\t\t\t\t\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/WebPage\" itemid=\"http:\/\/6344\" content=\"Genetically modified stem cells are effective against acute respiratory diseases\" \/><meta itemprop=\"datePublished\" content=\"2013-06-13\" \/><meta itemprop=\"dateModified\" content=\"2021-11-18\" \/><meta itemprop=\"name\" content=\"IDIBELL\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/en\/wp-content\/uploads\/sites\/2\/2022\/05\/Marca-B-e1651478109730.png\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/en\/author\/erigin\/\" \/><meta itemprop=\"name\" content=\"Idibell\" \/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/en\/wp-content\/uploads\/sites\/2\/2013\/06\/8023aran-1.jpg\" \/><meta itemprop=\"width\" content=\"300\" \/><meta itemprop=\"height\" content=\"168\" \/><meta itemprop=\"interactionType\" content=\"https:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/>\t\n\t\t\t\t<a href=\"https:\/\/idibell.cat\/en\/2013\/06\/genetically-modified-stem-cells-are-effective-against-acute-respiratory-diseases\/\" title=\"Genetically modified stem cells are effective against acute respiratory diseases\"><\/a>\n\t\t\t<a href=\"https:\/\/idibell.cat\/en\/2013\/06\/genetically-modified-stem-cells-are-effective-against-acute-respiratory-diseases\/\" title=\"Genetically modified stem cells are effective against acute respiratory diseases\">Genetically modified stem cells are effective against acute respiratory diseases<\/a>\n\t\t\tBy <a href=\"https:\/\/idibell.cat\/en\/author\/erigin\/\">Idibell<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t  |  \n\t\t\t\t\t\t\t\t\t13\/06\/2013\t\t\t\t\t\t\t\n\t\t<!-- .pp-content-posts -->\n\n","protected":false},"excerpt":{"rendered":"<p>Immune-inflammatory processes and gene therapeutics Summary The Immune-inflammatory Processes and Gene Therapy research group carries out translational research with a primary focus on the molecular basis of immune-inflammatory processes. Its aim is to promote relevant, high-quality research into inflammation and to provide an optimal environment for training young researchers. &nbsp; 88 Publications Strategic lines Expand [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":552,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"disabled","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"class_list":["post-2696","page","type-page","status-publish","hentry"],"publishpress_future_action":{"enabled":false,"date":"2024-12-25 10:43:10","action":"change-status","newStatus":"draft","terms":[],"taxonomy":""},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/pages\/2696","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/comments?post=2696"}],"version-history":[{"count":8,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/pages\/2696\/revisions"}],"predecessor-version":[{"id":24358,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/pages\/2696\/revisions\/24358"}],"up":[{"embeddable":true,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/pages\/552"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/media?parent=2696"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}